The main surprise is a higher full-year outlook, not a standout quarter. DEC raised 2026 adjusted EBITDA guidance to $960–$1,010 million from the prior $925–$975 million range, lifted adjusted free cash flow to approximately $440 million from approximately $430 million, and added $35–$50 million of operated-development spending. The production range barely changed, while the liquids mix improved to approximately 29%.
| Metric | 2Q26 | 2Q25 | 2026 updated outlook | Prior outlook |
|---|---|---|---|---|
| Adjusted EBITDA | $239.7M (Non-GAAP reconciliation) | $278.5M (Non-GAAP reconciliation) | $960–$1,010M (2026 Guidance) | $925–$975M |
| Adjusted EBITDA margin | 52% (Revenue reconciliation) | 64% (Revenue reconciliation) | — | — |
| Adjusted free cash flow | $114.5M (Free Cash Flow reconciliation) | $129.7M (Free Cash Flow reconciliation) | ~$440M (2026 Guidance) | ~$430M |
| Total production | 1,253 MMcfepd average (Production results) | — | 1,180–1,210 MMcfe/d (2026 Guidance) | 1,170–1,210 MMcfe/d |
| Capital expenditures | $40.4M (Free Cash Flow reconciliation) | $61.2M (Free Cash Flow reconciliation) | $225–$255M (2026 Guidance) | $205–$235M |
| Net debt / pro forma EBITDA | 2.45x (Leverage reconciliation) | 2.66x (Leverage reconciliation) | 2.0x–2.5x target (2026 Guidance) | 2.0x–2.5x target |
The underlying quarter was weaker year over year. Adjusted EBITDA fell to $239.7 million from $278.5 million, while adjusted EBITDA margin dropped to 52% from 64%; realized revenue per unit also declined to $4.22 per Mcfe from $4.75. The decline reflects lower divestiture proceeds and weaker operating leverage, even though total commodity revenue increased. (Financial Highlights; Revenue reconciliation)
Cash generation improved year to date, but the second quarter itself did not. Six-month adjusted free cash flow reached $274.2 million versus $191.9 million a year earlier, helped by higher operating cash flow and $125.6 million of divestiture proceeds. But second-quarter adjusted free cash flow was $114.5 million versus $129.7 million, and the current-year figure includes substantial asset-sale proceeds rather than being purely operating cash generation. (Free Cash Flow reconciliation)
The guidance increase is primarily acquisition- and portfolio-driven, with execution risk moving higher. Camino, the asset sales, synergies, and the new Oklahoma operated-development program support the higher outlook. However, capital spending rises to as much as $255 million, including $35–$50 million for a program whose material production contribution is expected in 2027. That makes the near-term upgrade more about integrating assets and monetizing the portfolio than about an immediate organic production acceleration. (2026 Guidance; Operated Development Program)
Balance-sheet progress is real but not clean-cut. Net debt increased to $2.83 billion from $2.56 billion year over year, yet leverage improved to 2.45x from 2.66x because pro forma trailing EBITDA grew to $1.15 billion. That places DEC inside its target range, but near its upper end. (Leverage reconciliation)
Net read: moderately better than the standing expectation. The raised EBITDA and free-cash-flow outlook, improved leverage, and new growth platform outweigh the soft second-quarter margin and cash-flow comparisons. Still, this is a narrow-to-moderate upgrade rather than a broad operational beat: production was largely maintained, and much of the improvement depends on acquisitions, divestitures, synergies, and future development execution.
Read the original 8-K on SEC EDGAR ↗